Lessons learned from gastric bypass operations in rats

Obesity Facts

Volumn 4, Issue SUPPL. 1, 2011, Pages 3-12

  Seyfried, Florian ^a,b   Le Roux, Carel W ^a   Bueter, Marco ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Animal model; Experimental design of rodent studies; Gastric bypass; Roux en Y gastric bypass; Surgical technique

Indexed keywords

CONFERENCE PAPER; DIETARY INTAKE; MORTALITY; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; ROUX Y ANASTOMOSIS; STANDARDIZATION; STOMACH BYPASS; SURGICAL TECHNIQUE; VAGUS NERVE;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC BYPASS; HUMANS; MALE; OBESITY, MORBID; RATS; WEIGHT LOSS;

EID: 79956092573     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000327301     Document Type: Conference Paper

References (119)

1. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC: Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-761. (Pubitemid 47295642)
2. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693. (Pubitemid 39665322)
3. Buchwald H, Oien DM: Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009;19:1605-1611.
4. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-752. (Pubitemid 47295641)
5. Mason EE, Printen KJ, Lewis JW, Scott DH, Blommers TJ: Gastric bypass criteria for effectiveness. Int J Obes 1981;5:405-411. (Pubitemid 11013324)
6. Ashrafian H, le Roux CW: Metabolic surgery and gut hormones - a review of bariatric entero-humoral modulation. Physiol Behav 2009;97:620-631.
7. Ashrafian H, Athanasiou T, Li JV, Bueter M, Ahmed K, Nagpal K, Holmes E, Darzi A, Bloom SR: Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev 2010; doi: 10.1111/j.1467-789X.2010.00802.x..
8. Le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR: Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006;243:108-114. (Pubitemid 43054062)
9. Le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lonroth H, Fandriks L, Ghatei MA, Bloom SR, Olbers T: Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246: 780-785. (Pubitemid 350035654)
10. Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L, Sjostrom L, Lonroth H: Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006;244:715-722. (Pubitemid 44629945)
11. Carrasco F, Papapietro K, Csendes A, Salazar G, Echenique C, Lisboa C, Diaz E, Rojas J: Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg 2007;17:608-616. (Pubitemid 46945428)
12. Sugerman HJ, Starkey JV, Birkenhauer R: A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205:613-624. (Pubitemid 17103382)
13. Thomas JR, Marcus E: High and low fat food selection with reported frequency intolerance following Roux-en-Y gastric bypass. Obes Surg 2008;18: 282-287.
14. Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR: Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010;34:462-471.
15. Lin E, Davis SS, Srinivasan J, Sweeney JF, Ziegler TR, Phillips L, Gletsu-Miller N: Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass. Am Surg 2009;75:498-502.
16. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, Ghatei MA, Bloom SR, Welbourn R, le Roux CW: Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010;252:966-971.
17. Bueter M, Lowenstein C, Ashrafian H, Hillebrand J, Bloom SR, Olbers T, Lutz T, le Roux CW: Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 2010;20:616-622.
18. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR, Sharkey KA, Lutz TA, le Roux CW: Gastric bypass increases energy expenditure in rats. Gastroenterology 2010;138:1845-1853.
19. Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiy S, Brookes PS, Niijima A, Inui A, Meguid MM: Characterization of weight loss and weight regain mechanisms after Rouxen- Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R1474-R1489. (Pubitemid 47535765)
20. Kirchner H, Guijarro A, Meguid MM: Is a model useful in exploring the catabolic mechanisms of weight loss after gastric bypass in humans? Curr Opin Clin Nutr Metab Care 2007;10:463-474. (Pubitemid 46934116)
21. Meguid MM, Ramos EJ, Suzuki S, Xu Y, George ZM, Das UN, Hughes K, Quinn R, Chen C, Marx W, Cunningham PR: A surgical rat model of human Roux-en-Y gastric bypass. J Gastrointest Surg 2004; 8:621-630. (Pubitemid 38881421)
22. Shin AC, Zheng H, Pistell PJ, Berthoud HR: Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond) 2010; doi:10.1038/ ijo.2010.174.
23. Stylopoulos N, Hoppin AG, Kaplan LM: Roux-en- Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring) 2009;17:1839-1847.
24. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V, Viollet B, Andreelli F, Withers DJ, Batterham RL: Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 2011;60:810-818.
25. Lan Z, Zassoko R, Liu W, Garcia B, Sun H, Wang R, Wang H: Development of techniques for gastrojejunal bypass surgery in obese mice. Microsurgery 2010;30:289-295.
26. Liu W, Zassoko R, Mele T, Luke P, Sun H, Liu W, Garcia B, Jiang J, Wang H: Establishment of duodenojejunal bypass surgery in mice: a model designed for diabetic research. Microsurgery 2008;28: 197-202. (Pubitemid 351458270)
27. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, Andreelli F: Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008;8:201-211.
28. Mason EE, Ito C: Gastric bypass in obesity. Surg Clin North Am 1967;47:1345-1351.
29. Nishie A, Brown B, Barloon T, Kuehn D, Samuel I: Comparison of size of proximal gastric pouch and short-term weight loss following routine upper gastrointestinal contrast study after laparoscopic Rouxen- Y gastric bypass. Obes Surg 2007;17:1183-1188. (Pubitemid 351321324)
30. O'Connor EA, Carlin AM: Lack of correlation between variation in small-volume gastric pouch size and weight loss after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008;4:399-403.
31. Roberts K, Duffy A, Kaufman J, Burrell M, Dziura J, Bell R: Size matters: gastric pouch size correlates with weight loss after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2007;21:1397-1402. (Pubitemid 47125065)
32. Stearns AT, Balakrishnan A, Rhoads DB, Ashley SW, Tavakkolizadeh A: Diurnal expression of the rat intestinal sodium-glucose cotransporter 1 (SGLT1) is independent of local luminal factors. Surgery 2009;145:294-302.
33. Wang Y, Liu J: Combination of bypassing stomach and vagus dissection in high-fat diet-induced obese rats-a long-term investigation. Obes Surg 2010;20: 375-379.
34. Tichansky DS, Boughter JD Jr, Harper J, Glatt AR, Madan AK: Gastric bypass surgery in rats produces weight loss modeling after human gastric bypass. Obes Surg 2008;18:1246-1250.
35. Furnes MW, Tommeras K, Arum CJ, Zhao CM, Chen D: Gastric bypass surgery causes body weight loss without reducing food intake in rats. Obes Surg 2008;18:415-422.
36. Zheng H, Shin AC, Lenard NR, Townsend RL, Patterson LM, Sigalet DL, Berthoud HR: Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol 2009;297:R1273-R1282.
37. Christou NV, Look D, Maclean LD: Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg 2006; 244:734-740. (Pubitemid 44629947)
38. Gleysteen JJ: Five-year outcome with gastric bypass: Roux limb length makes a difference. Surg Obes Relat Dis 2009;5:242-247.
39. Lee S, Sahagian KG, Schriver JP: Relationship between varying Roux limb lengths and weight loss in gastric bypass. Curr Surg 2006;63:259-263. (Pubitemid 44028508)
40. Choban PS, Flancbaum L: The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg 2002;12:540-545.
41. Feng JJ, Gagner M, Pomp A, Korgaonkar NM, Jacob BP, Chu CA, Voellinger DC, Quinn T, Herron DM, Inabnet WB: Effect of standard vs. extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2003;17:1055-1060. (Pubitemid 36808097)
42. Inabnet WB, Quinn T, Gagner M, Urban M, Pomp A: Laparoscopic Roux-en-Y gastric bypass in patients with BMI 50: a prospective randomized trial comparing short and long limb lengths. Obes Surg 2005;15:51-57 (Pubitemid 40203824)
43. Muller MK, Rader S, Wildi S, Hauser R, Clavien PA, Weber M: Long-term follow-up of proximal versus distal laparoscopic gastric bypass for morbid obesity. Br J Surg 2008;95:1375-1379.
44. Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R: Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 2008;4:521-525.
45. Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, Porter JL, Asplin J, Kuhn JA, Fordtran JS: The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr 2010;92:704-713.
46. Scopinaro N, Gianetta E, Pandolfo N, Anfossi A, Berretti B, Bachi V: Bilio-pancreatic bypass. Proposal and preliminary experimental study of a new type of operation for the functional surgical treatment of obesity (in Italian). Minerva Chir 1976;31: 560-566.
47. Glicksman C, Pournaras DJ, Wright M, Roberts R, Mahon D, Welbourn R, Sherwood R, Alaghband- Zadeh J, le Roux CW: Postprandial plasma bile acid responses in normal weight and obese subjects. Ann Clin Biochem 2010;47:482-484.
48. Knop FK: Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes? Am J Physiol Endocrinol Metab 2010; 299:E10-E13.
49. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H: Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009;58:1400-1407.
50. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science 1999;284:1362-1365. (Pubitemid 29289663)
51. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I: Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122: 248-256.
52. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-1630. (Pubitemid 34755670)
53. Pournaras DJ, le Roux CW: Obesity, gut hormones, and bariatric surgery. World J Surg 2009;33: 1983-1988.
54. Adrian TE, Ballantyne GH, Longo WE, Bilchik AJ, Graham S, Basson MD, Tierney RP, Modlin IM: Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut 1993;34:1219-1224. (Pubitemid 23274544)
55. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG: Central nervous system control of food intake. Nature 2000;404:661-671. (Pubitemid 30205071)
56. Schwartz MW, Morton GJ: Obesity: keeping hunger at bay. Nature 2002;418:595-597.
57. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-654.
58. Batterham RL, Cohen MA, Ellis SM, le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR: Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349:941-948. (Pubitemid 37064767)
59. Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2:1300-1304. (Pubitemid 17156636)
60. Farilla L, Bulotta A, Hirshberg B, Li CS, Khoury N, Noushmehr H, Bertolotto C, Di MU, Harlan DM, Perfetti R: Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003;144:5149-5158. (Pubitemid 37476040)
61. Meirelles K, Ahmed T, Culnan DM, Lynch CJ, Lang CH, Cooney RN: Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg 2009;249:277-285.
62. Shin AC, Zheng H, Townsend RL, Sigalet DL, Berthoud HR: Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010;151:1588-1597.
63. Taqi E, Wallace LE, de HE, Chelikani PK, Zheng H, Berthoud HR, Holst JJ, Sigalet DL: The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg 2010; 45:987-995.
64. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR: Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-2547. (Pubitemid 33642772)
65. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86:5992.
66. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormonereleasing acylated peptide from stomach. Nature 1999;402:656-660. (Pubitemid 129516334)
67. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-1719. (Pubitemid 33641587)
68. Callahan HS, Cummings DE, Pepe MS, Breen PA, Matthys CC, Weigle DS: Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab 2004;89:1319-1324. (Pubitemid 38368431)
69. Le Roux CW, Patterson M, Vincent RP, Hunt C, Ghatei MA, Bloom SR: Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab 2005;90:1068-1071. (Pubitemid 40279235)
70. Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA: Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003;88:3177-3183. (Pubitemid 36877491)
71. Sundbom M, Holdstock C, Engstrom BE, Karlsson FA: Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 2007;17:304-310. (Pubitemid 46659288)
72. Aprahamian CJ, Tekant G, Chen M, Yagmurlu A, Yang YK, Loux T, Harmon CM: A rat model of childhood diet-induced obesity: Roux-en-Y gastric bypass induced changes in metabolic parameters and gastric peptide ghrelin. Pediatr Surg Int 2007; 23:653-657. (Pubitemid 47013586)
73. Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM: Changes in GI hormones and their effect on gastric emptying and transit times after Rouxen- Y gastric bypass in rat model. Surgery 2005;138: 283-290.
74. Stock-Damge C, Aprahamian M, Raul F, Marescaux J, Scopinaro N: Small-intestinal and colonic changes after biliopancreatic bypass for morbid obesity. Scand J Gastroenterol 1986;21:1115-1123. (Pubitemid 17179103)
75. Le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R, Ghatei MA, Patel A, Bloom SR, Aylwin SJ: Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg 2010;252:50-56.
76. Stearns AT, Balakrishnan A, Tavakkolizadeh A: Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol 2009;297:G950-G957.
77. Berthoud HR: The vagus nerve, food intake and obesity. Regul Pept 2008;149:15-25.
78. Val-Laillet D, Biraben A, Randuineau G, Malbert CH: Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs. Appetite 2010;55:245-252.
79. Sobocki J, Fourtanier G, Estany J, Otal P: Does vagal nerve stimulation affect body composition and metabolism? Experimental study of a new potential technique in bariatric surgery. Surgery 2006;139:209-216. (Pubitemid 43170322)
80. Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M: The role of the gastric afferent vagal nerve in ghrelin- induced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120-1128.
81. Feldman M, Richardson CT: Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology 1986;90:428-433. (Pubitemid 16136687)
82. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM: Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991; 100:1311-1318.
83. Broglio F, Gottero C, Van KP, Prodam F, Destefanis S, Benso A, Gauna C, Hofland L, Arvat E, van der Lely AJ, Ghigo E: Acetylcholine regulates ghrelin secretion in humans. J Clin Endocrinol Metab 2004;89:2429-2433. (Pubitemid 38619886)
84. Le Roux CW, Neary NM, Halsey TJ, Small CJ, Martinez- Isla AM, Ghatei MA, Theodorou NA, Bloom SR: Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005;90:4521-4524. (Pubitemid 41159336)
85. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body weight. Nature 2006;443:289-295. (Pubitemid 44435142)
86. Konturek SJ, Kwiecien N, Obtulowicz W, Thor P, Konturek JW, Popiela T, Oleksy J: Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut 1987;28: 739-744. (Pubitemid 17082222)
87. Perathoner A, Weiss H, Santner W, Brandacher G, Laimer E, Holler E, Aigner F, Klaus A: Vagal nerve dissection during pouch formation in laparoscopic Roux-Y-gastric bypass for technical simplification: does it matter? Obes Surg 2009;19:412-417.
88. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR: The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005;1044:127-131. (Pubitemid 40616060)
89. Inoue H, Rubino F, Shimada Y, Lindner V, Inoue M, Riegel P, Marescaux J: Risk of gastric cancer after Roux-en-Y gastric bypass. Arch Surg 2007; 142:947-953. (Pubitemid 47607601)
90. Xu Y, Ohinata K, Meguid MM, Marx W, Tada T, Chen C, Quinn R, Inui A: Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss. J Surg Res 2002;107:56-63. (Pubitemid 35191813)
91. Mistry SB, Omana JJ, Kini S: Rat models for bariatric surgery and surgery for type 2 diabetes mellitus. Obes Surg 2009;19:655-660.
92. Feuers RJ, Duffy PH, Leakey JA, Turturro A, Mittelstaedt RA, Hart RW: Effect of chronic caloric restriction on hepatic enzymes of intermediary metabolism in the male Fischer 344 rat. Mech Ageing Dev 1989;48:179-189. (Pubitemid 19130666)
93. Hajnal A, Kovacs P, Ahmed T, Meirelles K, Lynch CJ, Cooney RN: Gastric bypass surgery alters behavioral and neural taste functions for sweet taste in obese rats. Am J Physiol Gastrointest Liver Physiol 2010;299:G967-G979.
94. Xu Y, Ramos EJ, Middleton F, Romanova I, Quinn R, Chen C, Das U, Inui A, Meguid MM: Gene expression profiles post Roux-en-Y gastric bypass. Surgery 2004;136:246-252. (Pubitemid 39037661)
95. Meguid MM: In the matter of sex...sex matters in medical-scientific research. Nutrition 2008;24:767-768. (Pubitemid 351790759)
96. Riesenfeld A: Constitution and body proportions in different strains of rats. A study of race formation in breeding isolates. Acta Anat (Basel) 1976; 94:169-183.
97. Czaja JA: Sex differences in the activational effects of gonadal hormones on food intake and body weight. Physiol Behav 1984;33:553-558. (Pubitemid 15201813)
98. Gentry RT, Wade GN: Sex differences in sensitivity of food intake, body weight, and runningwheel activity to ovarian steroids in rats. J Comp Physiol Psychol 1976;90:747-754.
99. Akiyama T, Tachibana I, Shirohara H, Watanabe N, Otsuki M: High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Res Clin Pract 1996;31:27-35.
100. Bueter M, Ashrafian H, Frankel AH, Tam FW, Unwin RJ, le Roux CW: Sodium and water handling after gastric bypass surgery in a rat model. Surg Obes Relat Dis 2010.
101. Quinn R: Comparing rat's to human's age: how old is my rat in people years? Nutrition 2005;21: 775-777. (Pubitemid 40733575)
102. Sjostrom L: Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008;32(suppl 7): S93-S97.
103. Bjorklund P, Laurenius A, Een E, Olbers T, Lonroth H, Fandriks L: Is the Roux limb a determinant for meal size after gastric bypass surgery? Obes Surg 2010;20:1408-1414.
104. Akkary E, Sidani S, Boonsiri J, Yu S, Dziura J, Duffy AJ, Bell RL: The paradox of the pouch: prompt emptying predicts improved weight loss after laparoscopic Roux-Y gastric bypass. Surg Endosc 2009;23:790-794.
105. Meguid MM, Glade MJ, Middleton FA: Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition 2008;24:832-842.
106. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL: Is the energy homeostasis system inherently biased toward weight gain? Diabetes 2003;52:232-238. (Pubitemid 36173173)
107. Miras AD, le Roux CW: Bariatric surgery and taste: novel mechanisms of weight loss. Curr Opin Gastroenterol 2010;26:140-145.
108. Tichansky DS, Rebecca GA, Madan AK, Harper J, Tokita K, Boughter JD: Decrease in sweet taste in rats after gastric bypass surgery. Surg Endosc 2010.
109. Flancbaum L, Choban PS, Bradley LR, Burge JC: Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery 1997;122:943-949. (Pubitemid 27495936)
110. Wolff BS, Meirelles K, Meng Q, Pan M, Cooney RN: Roux-en-Y gastric bypass alters small intestine glutamine transport in the obese Zucker rat. Am J Physiol Gastrointest Liver Physiol 2009;297: G594-G601.
111. Stylopoulos N, Davis P, Pettit JD, Rattner DW, Kaplan LM: Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats. Surg Endosc 2005;19:942-946. (Pubitemid 41279586)
112. Li Z, Zhang HY, Lv LX, Li DF, Dai JX, Sha O, Li WQ, Bai Y, Yuan L: Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats. World J Gastro enterol 2010;16:2244-2251.
113. Guijarro A, Kirchner H, Meguid MM: Catabolic effects of gastric bypass in a diet-induced obese rat model. Curr Opin Clin Nutr Metab Care 2006; 9:423-435. (Pubitemid 44097813)
114. Guijarro A, Osei-Hyiaman D, Harvey-White J, Kunos G, Suzuki S, Nadtochiy S, Brookes PS, Meguid MM: Sustained weight loss after Rouxen- Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg 2008;247:779-790. (Pubitemid 351591513)
115. Peng Y, Rideout DA, Rakita SS, Gower WR, Jr., You M, Murr MM: Does LKB1 mediate activation of hepatic AMP-protein kinase (AMPK) and sirtuin1 (SIRT1) after Roux-en-Y gastric bypass in obese rats? J Gastrointest Surg 2010;14:221-228.
116. Rideout DA, Peng Y, Rakita SS, Desai K, Gower WR Jr, You M, Murr MM: Roux-en-Y gastric bypass alters tumor necrosis factor-alpha but not adiponectin signaling in immediate postoperative period in obese rats 1. Surg Obes Relat Dis 2010; 6:676-680.
117. Ramos EJ, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, Inui A, Das U, Meguid MM: Is obesity an inflammatory disease? Surgery 2003;134: 329-335. (Pubitemid 37070357)
118. Romanova IV, Ramos EJ, Xu Y, Quinn R, Chen C, George ZM, Inui A, Das U, Meguid MM: Neurobiologic changes in the hypothalamus associated with weight loss after gastric bypass. J Am Coll Surg 2004;199:887-895. (Pubitemid 39539236)
119. Young EA, Taylor MM, Taylor MK, McFee AS, Miller OL, Gleiser CA: Gastric stapling for morbid obesity: gastrointestinal response in a rat model. Am J Clin Nutr 1984;40:293-302. (Pubitemid 14065387)